C-CDA on FHIR, published by HL7 International / Cross-Group Projects. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ccda-on-fhir/ and changes regularly. See the Directory of published versions
Though feedback is welcome on any part of the IG, only changed content may be voted upon during an STU ballot. The following is a high-level list of changes since version 1.2.0 STU1.
New Resources / Guidance
Updated Mappings
During the 2023 & 2024 connectathons, several mappings were enhanced. These updates addressed gaps for fields required by C-CDA or USCDI and included non-controversial mappings. For guidance on handling unmapped fields, refer to the Missing Maps section.
approachSiteCode
, maxDoseQuantity
, administrationUnitCode
, manufacturerOrganization
, Drug Vehicle
, andSupply
.raceCode/originalText
as well as mappings for religiousAffiliationCode
, guardian
, birthPlace
, languageCommunication/modeCode
, languageCommunication/proficiencyLevelCode
, and providerOrganization
.Age Observation
and Supporting Observations (e.g. Assessment Scale Observation)
.Additionally, all highlighted examples have been converted to inline HTML to facilitate searching, resizing, and copy-pasting.